Matthew W. HALEY,Jeanne HO,Hyunsoo PARK,Roxana F. SCHLAM,Chenkou WEI
申请号：
US15563659
公开号：
US20180094019A1
申请日:
2016.04.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to crystalline forms of modified triterpenoid hydrochloride salts with HIV maturation inhibitor activity. More specifically, the present invention relates to the H-4, T1F-1, and T1F-2 crystalline forms. The present invention also relates to pharmaceutical compositions comprising these crystalline forms, as well as to methods of using these crystalline forms for the treatment of the HIV virus, and methods for obtaining these crystalline forms.
